Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CORIN: Icotinib vs Observation in Resected Stage IB EGFR+ NSCLC
NCT02264210Phase 2Completed
- Sponsor
- Sun Yat-sen University
- Start
- Jan 2015
- Primary completion
- Dec 2020
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of ethinylestradiol + levonorgestrel in non-small cell lung cancer (NSCLC), sponsored by Sun Yat-sen University. Primary endpoint: Disease-Free Survival at 3 years. Started Jan 2015; status: completed.
02
Drugs
ethinylestradiol + levonorgestrel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02264210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02264210.